Digital PNG artwork · delivered by email | Secure checkout · no physical shipping
Hedi Raizer

Journal 6 min read

What markers track sarcopenia?

Sarcopenia is defined by low muscle strength and mass. This page reviews the markers and mechanisms under investigation in registered trials and recent reviews, including muscle biopsies, blood biomarkers, imaging, and f

peptides-pro Editorial

What markers track sarcopenia?

Sarcopenia is the age-related loss of muscle strength and mass. It has consensus criteria on three continents and an all-cause mortality hazard ratio near 1.6 [4]. The condition is identified through assessments of muscle strength, muscle mass, physical function, pain, and quality of life [1]. No drug is approved for the primary age-related condition, and agents that reliably enlarge muscle have not improved the strength and gait-speed endpoints that define it [4].

Research into sarcopenia markers centres on the biology of force production in skeletal muscle. Ageing degrades four properties that jointly determine force output: innervation, through motor-unit loss and failed compensatory reinnervation; metabolic competence, through declining mitochondrial content and respiratory capacity; regenerative capacity, through satellite-cell dysfunction; and the force-producing fraction of the muscle tissue itself [4].

Research Studies

Screening and postoperative exercise in advanced coxarthrosis

The SARCO-COX study evaluates whether screening for sarcopenia in adults aged 65 years or older with advanced hip osteoarthritis, followed by a structured postoperative exercise program, improves recovery after total hip replacement surgery compared with standard care. Participants undergo assessments of muscle strength, muscle mass, physical function, pain, and quality of life before surgery and during follow-up. Blood samples and a small muscle biopsy obtained during the planned surgery are analyzed to study biomarkers related to muscle health. A total of 150 people are expected to participate [1].

Pulsed electromagnetic field therapy in elderly community residents

A clinical study is investigating whether pulsed electromagnetic field therapy improves frailty and sarcopenia in elderly community residents. The trial follows a defined procedure beginning with informed consent and screening to determine eligibility [2].

Malnutrition and metabolic failure in high-potency incretin therapy

A systematic review and meta-analysis synthesized data from 19 randomized trials across the SURMOUNT, STEP, SCALE, and OASIS programs to quantify the nutritional and body composition consequences of high-potency incretin therapy in adults with obesity. The review followed PRISMA 2020 guidelines, assessed risk of bias using the Cochrane RoB2 tool, and rated certainty of evidence using GRADE. Continuous outcomes were pooled using mean differences within a random-effects model. The authors note that substantial weight loss was achieved, but the extreme energy deficits induced may obscure underlying nutritional deterioration [3].

The force-producing fraction as a therapeutic target

A review approaches the translational failure in sarcopenia from the biology rather than the pipeline. It argues that ageing degrades four properties of skeletal muscle that jointly determine force production and are each druggable in principle: innervation, metabolic competence, regenerative capacity, and the force-producing fraction. The review proposes muscle quality as a therapeutic target and a design framework for trials that can test it [4].

HB05P and muscle strength in sarcopenia or possible sarcopenia

A pilot study is evaluating whether HB05P, a health functional food ingredient containing pasteurized Akkermansia muciniphila HB05, improves muscle strength and to evaluate its safety. This is a randomized, double-blind, placebo-controlled, parallel-group, single-center study. A total of 80 adults aged 50 to under 80 years who meet the 2025 Asian Working Group for Sarcopenia (AWGS) criteria for sarcopenia or possible sarcopenia will be randomly assigned in a 1:1 ratio to the test group or the control group. Participants will take one 430 mg hard capsule once daily with water after breakfast for 168 days (24 weeks). The test capsule contains 150 mg of HB05P (3 x 10^10 c) [5].

Strength training combined with algae-derived DHA or fish-derived EPA and DHA

A study is evaluating the effects of 12-week supplementation with algae-derived DHA combined with strength training on muscle strength, neuromuscular parameters, post-exercise inflammation, and cognitive functions in healthy adults compared to fish-derived EPA and DHA combined with strength training, strength training alone, and a control group. Body composition is assessed prior to the training intervention and after 12 weeks of training: body mass index (BMI) and body composition — fat mass [kg], body fat percentage [%], and skeletal muscle mass [kg] — are determined using bioimpedance methods (In Body 720, Biospac) [6].

Pre-operative sarcopenia and functional recovery after hip arthroplasty

A single-centre, exploratory study at Montpellier University Hospital is investigating whether having low muscle mass and strength before hip-replacement surgery, a condition called sarcopenia, impacts the return to everyday independence in people aged 75 years or older. About 20 volunteers, scheduled for surgery because of a recent femoral-neck fracture or severe arthritis that no longer responds to usual care, will give consent, answer brief health questionnaires, attempt simple walking and chair-rise tests if possible, and provide a small blood sample. While they are already under anaesthesia for their planned operation, the surgical team will take a tiny muscle sample through the same [7].

Exercise and nutritional intervention in melanoma patients receiving immunotherapy

A randomized study is evaluating whether a six-month program of structured resistance exercise combined with individualized nutritional support can preserve or improve skeletal muscle mass and muscle quality in adults with stage II to IV malignant melanoma who are starting treatment with immune checkpoint inhibitors. Participants are randomly assigned either to the exercise and nutritional intervention in addition to standard oncology care or to standard oncology care alone. The study aims to obtain complete measurements from at least 40 participants. Assessments are performed at baseline, after 3 months, and after 6 months, and include magnetic resonance i [8].

Reference-only findings

A scoping review examined coffee and coffee-derived bioactive compounds in skeletal muscle health, covering mechanistic pathways, preclinical evidence, and human outcomes. Coffee is a complex source of bioactive compounds, including caffeine, (poly)phenols, trigonelline, and diterpenes. Although habitual coffee consumption has been associated with metabolic benefits, its relationship with skeletal muscle health remains incompletely understood [9].

A source-verified scoping evidence map and translational review assessed anti-osteoporotic drugs as candidate dual bone-muscle therapies in osteosarcopenia. The authors note that clinical claims often conflate biological plausibility, observational signals, and randomized efficacy [10].

A 32-week randomized controlled trial and molecular mechanism study explored the intervention effect and molecular mechanism of resistance training based on precise mechanical load monitoring on patients with primary osteoporosis complicated by osteosarcopenia. The work reports that precise resistance training alleviates osteosarcopenia via the GLP-1/myostatin path [11].

A study reports that Bifidobacterium adolescentis-derived nicotinic acid improves host skeletal muscle mitochondrial function to ameliorate sarcopenia [12].

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only. We do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician.

Sources

WhatsApp